Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Hyperhidrosis: Nuanced Techniques for Optimal Outcomes with Oral Medications and Botulinum Toxins
Description
The discussion revolves around managing hyperhidrosis through advanced techniques, particularly focusing on botulinum toxins and oral medications. Botulinum toxins are FDA approved specifically for treating axillary sweating, and the recommended dose is 100 units, divided between both axillae. Different injection techniques and assessments, such as the starch iodine test, help determine effective treatment areas and track patient progress. While botulinum toxin is effective for axillary sweating with results lasting around six months, it is also utilized off-label for other areas like palms and facial sweating, which present unique challenges. Systemic agents such as anticholinergics, beta blockers, and clonidine can be employed, particularly when first-line therapies fall short. Anticholinergics are especially indicated to manage generalized sweating, while beta blockers help control situational sweating related to stress. The presentation emphasizes the importance of careful patient assessment, adherence to dosing adjustments, and monitoring for side effects. Resources for further information include the International Hyperhidrosis Society's website, which provides additional educational materials on hyperhidrosis management.
View moreConclusions
- Microwave thermolysis is currently limited to axillary use.
- Botulinum toxin (specifically OnabotulinumtoxinA) is FDA-approved for treating excessive sweating in the axilla.
- The approved dosage for treating axillary hyperhidrosis is 50 units per axilla.
- The HDSS scale effectively measures treatment outcomes for hyperhidrosis.
- Botulinum toxin efficacy does not significantly improve when increasing the dose beyond 50 units.
- Patients report minimal side effects such as bruising and tenderness from botulinum toxin injections.
- Personalized treatment using starch iodine testing can optimize injection sites for better outcomes.
- Botulinum toxin effects typically last about six months, with a gradual return of symptoms around four months after treatment.
- In cases of inadequate results with standard doses, increasing the botulinum toxin dosage can improve effectiveness.
- For palmar hyperhidrosis, more frequent and closer injections are necessary due to tenderness and proximity to muscles.
- Propranolol can be effective for anxiety-induced sweating by administrating before stressful events.
- Anticholinergics, such as glycopyrrolate and oxybutynin, can be used off-label for multiple sweating areas but come with potential side effects.
- Topical and systemic therapies should not be combined without careful assessment due to potential side effects.
- The targeted alkali thermolysis patch is a promising new method to reduce sweating and odors in specific areas.
- Understanding the anatomy and dynamics of sweating can enhance therapeutic targeting for botulinum toxin injections.
- Lowe NJ, Glaser DA, Eadie N, et al. JAAD Apr;56(4):604-11, 2007.
- Grunfeld A, Murray CA, Solish N. Botulinum toxin for hyperhidrosis: A Review. Am J Clin Dermatol 2009; 10(2): 87-102.
- Dobson. Arch Dermatol 1987;123:883.
- Atkins. Plast Reconstr Surg 2002;110:222.
- Boni. Curr Probl Dermatol 2002;30:44.
- James Arch Dermatol 1987;123-925
- Sato. J Am Acad Dermatol 1989;20:537.
- Kuritzky. Arch Neurol 1984;41:1210
- Feder. J Clin Psychiatry 1995;56:35.
- Tkach. J Am Acad Dermatol 1982;6:545.
- BJD 2007. 157:118-121.
- Paller et al. Oral glycopyrrolate as second line treatment for primary pediatrics HH. JAAD 2012.
- Wolosker N et al. A randomized placebo-controlled trial of oxybutynin for the initial treatment of palmar & axillary HH. J Vasc Surg 2012, 55:1696-700.
- Derm Surg. 2022 Nov 1;48(11):1220-1225.